| Date | Time | Source | Headline | Symbol | Company |
| 08/26/2024 | 12:00AM | PR Newswire (US) | True Story Proves How God's Help, Hard Work and Never Giving Up Leads to Accomplishing Great Things in Life | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | New Poetry Book Invites Readers to Reflect, Imagine and Connect | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | TaiwanPlus Celebrates Three Years as a Leading International Media Organization, Nearing 200 Million Global Views | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | Discover Macao: Win Exclusive Tours with "Experience Macao Limited Edition" Online Quiz Game | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | 30-Day Devotional Makes the Perfect Daily Motivation Tool to Become the Person God Created You to Be | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | Discover Macao: Win Exclusive Tours with "Experience Macao Limited Edition" Online Quiz Game | | |
| 08/26/2024 | 12:00AM | PR Newswire (Canada) | Celebrating 35 Years of Innovation: Microland Marks Milestone with Groundbreaking Solutions and Vision for the Future | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | Celebrating 35 Years of Innovation: Microland Marks Milestone with Groundbreaking Solutions and Vision for the Future | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | Juvenile Fiction About a Gymnastics Team Spins a Memorable Lesson On the Importance of Sportsmanship | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | See How Jesus Cares For His Bride As Both Bridegroom And Builder | | |
| 08/26/2024 | 12:00AM | PR Newswire (Canada) | Discover Macao: Win Exclusive Tours with "Experience Macao Limited Edition" Online Quiz Game | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | Celebrating 35 Years of Innovation: Microland Marks Milestone with Groundbreaking Solutions and Vision for the Future | | |
| 08/26/2024 | 12:00AM | PR Newswire (Canada) | Découvrez Macao : gagnez des visites exclusives avec le jeu-questionnaire en ligne Experience Macao Limited Edition | | |
| 08/26/2024 | 12:00AM | PR Newswire (US) | Author Considers What She Will Give In Exchange For Her Soul | | |
| 08/25/2024 | 10:30PM | Business Wire | Discover® Global Network Study: 91% of Asia-Pacific Businesses Prioritize Fraud Prevention Services, Appeal for Virtual Card Numbers Grows | NYSE:DFS | Discover Financial Services |
| 08/25/2024 | 10:23PM | PR Newswire (Canada) | Investor Update Webcast - FY24 Financial Results | TSX:WGX | Westgold Resources Limited |
| 08/25/2024 | 10:23PM | PR Newswire (Canada) | Investor Update Webcast - FY24 Financial Results | TSX:KRR | Karora Resources Inc |
| 08/25/2024 | 10:00PM | Business Wire | PPG completes expansion of industrial coatings plant in Vietnam | NYSE:PPG | PPG Industries Inc |
| 08/25/2024 | 9:00PM | Business Wire | Singtel and Hitachi Expand Collaboration to Next-Generation Data Centers and GPU Cloud to Accelerate Enterprise Digital Transformation by AI Adoption | | |
| 08/25/2024 | 9:00PM | Business Wire | Berkshire Hathaway Specialty Insurance Makes Leadership Appointments in Asia | | |
| 08/25/2024 | 8:14PM | Business Wire | ALAFIA、医療分野における人工知能ソフトウェアアプリケーションのためのオールインワンのインタラクティブな高性能パーソナルスーパーコンピュータAIVASを発表 | | |
| 08/25/2024 | 7:45PM | Business Wire | State Street Global Advisors Takes Strategic Stake in Leading Australian Fintech Platform Raiz | NYSE:STT | State Street Corporation |
| 08/25/2024 | 7:45PM | Business Wire | State Street Global Advisors Takes Strategic Stake in Leading Australian Fintech Platform Raiz | ASX:RZI | Raiz Invest Limited |
| 08/25/2024 | 7:44PM | PR Newswire (US) | 2024 Belt and Road Journalists Forum to Be Held in Chongqing | | |
| 08/25/2024 | 7:05PM | Business Wire | 欧州委員会がセルトリオンのSteQeyma®（CT-P43）を承認、Stelara®（ウステキヌマブ）のバイオシミラーとして多数の慢性炎症性疾患治療で使用可能に | | |
| 08/25/2024 | 7:01PM | Business Wire | La Commissione europea approva SteQeyma ® (CT-P43) di Celltrion, un biosimilare di Stelara® (ustekinumab), per il trattamento di diverse malattie infiammatorie croniche | | |
| 08/25/2024 | 6:58PM | Business Wire | La Commission européenne approuve SteQeyma ® (CT-P43) de Celltrion , un produit biosimilaire de Stelara® (ustekinumab), destiné au traitement de diverses maladies inflammatoires chroniques | | |
| 08/25/2024 | 6:57PM | Business Wire | European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases | | |
| 08/25/2024 | 6:57PM | Business Wire | Europäische Kommission erteilt Zulassung für SteQeyma® (CT-P43) von Celltrion – einem Biosimilar zu Stelara® (Ustekinumab) – für die Behandlung mehrerer chronisch-entzündlicher Erkrankungen | | |
| 08/25/2024 | 6:43PM | PR Newswire (Canada) | Avis aux médias - Itinéraire de la vice-première ministre pour le lundi 26 août 2024 | | |